Skip to main content
Premium Trial:

Request an Annual Quote

MNM Bioscience Wins $800K Eurostars Grant to Stratify Ovarian Cancer Patients

NEW YORK – Bioinformatics startup MNM Bioscience said Monday that it has received an $800,000 Eurostars grant to develop a software tool for the stratification of patients with ovarian cancer.

The Cambridge, Massachusetts-based firm will work with partner Macrogen Europe to develop a product called PARPiNDx, which will apply artificial intelligence to whole-genome sequencing data to find patients likely to respond to PARP inhibitors, as well as those with intrinsic resistance to the drug family.

MNM Bioscience said that it entered into a consortium agreement with Macrogen Europe on March 24. Neither company provided additional details about their consortium.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.